Baldwin Brothers LLC Nuvectis Pharma, Inc. Transaction History

Baldwin Brothers LLC

$1.45 Billion
Q3 2025

A detailed history of Baldwin Brothers LLC transactions in Nuvectis Pharma, Inc. stock. As of the latest transaction made, Baldwin Brothers LLC holds 350,461 shares of NVCT stock, worth $2.11 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

350,461

Previous 350,461 -0.0%

Holding current value

$2.11 Million

Previous $2.62 Million 19.41%

% of portfolio

0.15%

Previous 0.19%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 24, 2025	SELL	$7.47 - $10.96 $59,760 - $87,680	-8,000 Reduced 2.23%	350,461 $2.62 Million
Q1 2025 Apr 14, 2025	BUY	$5.37 - $10.46 $13,425 - $26,150	2,500 Added 0.7%	358,461 $3.75 Million
Q4 2024 Jan 22, 2025	BUY	$4.52 - $10.98 $821,876 - $2 Million	181,831 Added 104.42%	355,961 $1.93 Million
Q3 2024 Oct 15, 2024	BUY	$6.16 - $7.23 $33,880 - $39,765	5,500 Added 3.26%	174,130 $1.1 Million
Q2 2024 Jul 12, 2024	BUY	$5.98 - $8.25 $86,710 - $119,625	14,500 Added 9.41%	168,630 $1.07 Million

Q1 2024 Apr 12, 2024	BUY	$6.69 - $11.0 $80,882 - $132,990	12,090 Added 8.51%	154,130 $1.26 Million
Q4 2023 Jan 08, 2024	BUY	$7.85 - $11.78 $201,431 - $302,274	25,660 Added 22.05%	142,040 $1.18 Million
Q3 2023 Oct 10, 2023	BUY	$12.89 - $16.29 $339,251 - $428,736	26,319 Added 29.22%	116,380 $1.5 Million
Q2 2023 Jul 14, 2023	SELL	$12.62 - $18.4 $678,186 - $988,797	-53,739 Reduced 37.37%	90,061 $1.44 Million
Q1 2023 Apr 21, 2023	BUY	$7.32 - $14.37 $76,860 - $150,885	10,500 Added 7.88%	143,800 $1.89 Million
Q4 2022 Jan 27, 2023	BUY	$6.7 - $7.74 $2,010 - $2,322	300 Added 0.23%	133,300 $0
Q3 2022 Oct 14, 2022	BUY	$7.09 - $13.0 $85,080 - $156,000	12,000 Added 9.92%	133,000 $943,000
Q2 2022 Jul 18, 2022	BUY	$7.02 - $20.44 $849,420 - $2.47 Million	121,000 New	121,000 $1.36 Million

Others Institutions Holding NVCT

# of Institutions

Shares Held

3.62M

Call Options Held

97.7K

Put Options Held

View Full List

About Nuvectis Pharma, Inc.

Ticker NVCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,642,500
Market Cap $88.1M
Description
Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. It develops NXP800, a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers; and NXP900, a small molecule drug candidate to inhibit the Proto-oncogene c-Src...

More about NVCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baldwin Brothers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baldwin Brothers LLC with notifications on news.

Account

Baldwin Brothers LLC Nuvectis Pharma, Inc. Transaction History